If I Had $1,000 Invest, Here's Tech Stock to Buy Before Micron
Got $1,000 to invest? This article outlines a real-world plan, explains why Nvidia makes sense before Micron, and giv...
Why Budgeting Is Hard For Many People
Unpack the common reasons budgeting is hard and learn approachable methods to develop healthier financial habits.
24,094 articles
Oil Near $100 Barrel, Here’s the ETF Investors Should Buy
Oil trades around the $100 barrel mark as investors seek safety. This piece identifies a top defensive ETF and explai...
Down Still Dominant: Growth Stock Worth Buying Now
When a growth stock plunges by half, investors often panic. But a durable business model, strong margins, and a clear...
Stocks Down Right Hold: 2 Bargains to Buy Now for the Decade
Beaten-down brands aren’t a bet on luck—they’re a test of resilience. This piece explores two stocks down right hold ...
Billionaire Bill Ackman Sold: 2 AI Stocks to Watch Now
Billionaire Bill Ackman recently shifted gears, selling a former cornerstone stake to fund two AI stock bets. This mo...
Is Meta's Spending Spree Reckless or Genius for Investors?
Meta Platforms is betting big on AI and cloud tech, fueling debate over whether meta's spending spree reckless moves ...
Under Greg Abel, Apple and Alphabet Berkshire Portfolio
Berkshire Hathaway is changing under Greg Abel, shifting toward concentrated bets on Apple and Alphabet. This article...
Survival Only Success: A Compass for Smart Investing
When markets swing, the first victory is staying solvent. This guide explains how a survival-first mindset can delive...
Prediction: Spacex Will Greatest IPO Fleece Risk for Retail
SpaceX IPO chatter has investors buzzing and critics worried. This piece breaks down why the hype could outpace reali...
Genedx Stock Plummeting Today: Why the Selloff Continues
Biotech stocks can swing wildly on quarterly results and guidance. This article unpacks why genedx stock plummeting t...
CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status